We observed the High‐High group was associated with PDL1 up‐regulation in the tumor, Tbet+ CD4+ T cells circulating in the peripheral blood and a gene signature characterised by a robust IFN‐γ response, antigen processing and presentation via MHC‐I pathways. The gene discussed is CD4; the disease is neoplasm.